Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Flavonones has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Hesperidin and naringin sit in the same citrus fruit as ascorbate, which is why old formulations paired them and called the flavanone fraction vitamin P. Ascorbate reduces the phenoxyl radical formed when a flavanone quenches an oxidant, returning it to the parent phenol. The chemistry is settled; a clinical consequence of the pairing is not.
Hesperidin and naringin carry disaccharide sugars that resist brush border hydrolysis, so absorption waits for colonic bacterial rhamnosidase to release hesperetin and naringenin. Plasma appearance is delayed by six hours or more and varies widely between people according to which organisms they carry. Someone lacking the relevant rhamnosidase activity absorbs very little of an oral dose.
Flavanone aglycones have low aqueous solubility and can precipitate before absorption. Phospholipid dispersions and micronised preparations keep more in solution through the small intestine. This changes how much gets in, not what the molecule does once it is in.
Both classes are substrates for intestinal and hepatic UGT and SULT enzymes, and those enzymes saturate. High combined intake can raise circulating unconjugated levels of one or the other beyond what either dose predicts. This is a pharmacokinetic interaction, not a benefit claim.
Flavanones bind ferrous and ferric iron and lower the fraction of a non-heme iron dose available for uptake. The effect is smaller than for catechol-rich flavonols because the flavanone B ring is often monohydroxylated, but it is present. Spacing the two doses apart handles it.
The micronised purified flavonoid fraction used in circulatory formulations is roughly nine parts diosmin to one part hesperidin, and diosmin itself is manufactured from hesperidin by oxidation. The pairing is a manufacturing and formulation convention with a long commercial history. It is convention plus shared chemistry, not two independent mechanisms.
Bioflavonoid complexes have combined a flavonol rutinoside with a flavanone rutinoside since the 1940s, and both depend on the same bacterial rhamnosidase step for absorption. The combination raises total flavonoid intake across two subclasses. The shared activation route means neither compensates for a gut that does not carry the enzyme.
Nothing specific on file for Flavonones. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.